SectorBiological Technology
Established Date03/06/2010
Listing Date23/12/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees15
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1000 N. West Street, Suite 1200, Wilmington, DE 19801
Business
IntroductionInhibikase Therapeutics, Inc., was incorporated as a Delaware corporation on June 3, 2010. The company is a clinical-stage pharmaceutical company developing therapies for Parkinson's disease or PD and related diseases that occur inside and outside the brain.
